Rachelle Doody, Global Head of Neurodegeneration at Roche, discusses her personal interest in Alzheimer’s and Roche’s current research pipeline.
Listen our recent panel discussion, held in collaboration with The Drake Foundation, to hear from our experts as they discuss the current issues surrounding brain banking.
Dr Lin tells Lauren Pulling (Editor, NC) about his work as a pediatric neurologist, and recent advances in deep brain stimulation for infants.
Megan Zuelsdorff discusses her research into the impact of lifetime stressful experiences on cognition as part of the Wisconsin Registry for Alzheimer’s Prevention Study.
In a podcast recorded live at AAIC in London, Kim Mueller talks about her group’s novel study; the largest prospective, longitudinal study of spontaneous speech samples in a study group of its kind.
While at AAIC 2017 in London, Lauren Pulling (Editor, NC) spoke to Julie Williams about her extensive work in Alzheimer’s genetics and risk factors.
Dr Vitek discusses the Neuromodulation Research Center, progression in the field, and the biggest challenges associated with developing new neuromodulation therapies for conditions such as Parkinson’s disease.
In this interview, Prof Wischik discusses his 30 years’ experience in the field, the latest developments at TauRx, and what we can expect from tau research the next 10 years.
Could this new approach drive Parkinson’s disease into the age of personalized medicine?
We caught up with Regina Katzenschlager at AAN 2017, whose research into the use of apomorphine for Parkinson’s disease was highlighted at the conference as one to watch.